Blog - Page 4080 of 5386

MondayNov 03, 2008 4:13 am

Misonix, Inc. (NASDAQ: MSON)

Misonix, Inc. (NASDAQ: MSON) has their efforts focused on designing, developing, and manufacturing one of the broadest ranges of Therapeutic Ultrasonic Medical Devices. The company’s aim is to develop products that will improve patients’ quality of life by incorporating the highest level of quality and innovation into each and every product. Current application of their technology ranges from kidney stone pulverization and the aspiration of brain tumors to the latest technological breakthrough HIFU (High Intensity Focused Ultrasound) for various cancer treatments. For further information, visit the Company's web site at www.misonix.com.

MondayNov 03, 2008 4:12 am

American Lorain Corporation (OTC BB: ALRC)

American Lorain Corporation (OTC BB: ALRC) is a currently inactive shell company open to securing a business partnership with an enterprise that it may acquire, merge with or become engaged in. Considered a development stage company as defined in the Statement of Financial Accounting Standards No. 7, American Lorain Corporation currently has no on-going operations and has not secured any specific business partnership nor has the company entered into any agreements or arrangements at this time.

MondayNov 03, 2008 4:12 am

MiMedx Group, Inc. (OTC BB: MDXG)

MiMedx Group, Inc. (OTC BB: MDXG)is focused on developing biomaterial-based products for application in the musculoskeletal specialties. The company intends to leverage their experienced management team to commercializes medical technologies by facilitating their progression through the proper regulatory approval processes, arranging for reliable and cost-effective manufacturing, and delivering these products to markets throughout the world. For further information, visit the Company's web site at www.mimedx.com.

MondayNov 03, 2008 4:11 am

Millennium India Acquisition Company, Inc. (NASDAQ: SMCG)

Millennium India Acquisition Company, Inc. (NASDAQ: SMCG) is a closed-end, non-diversified management investment company that is focused on emerging market leaders in the Indian economy. Recently, the young company made news when it announced an online trading alliance with Punjab National Bank, which is India’s second largest public-sector commercial bank. With new alliances and an aggressive style, Millennium has a strong grasp on the future.

MondayNov 03, 2008 4:11 am

Amarin Corporation plc (NASDAQ: AMRN)

Amarin Corporation plc (NASDAQ: AMRN), a clinical-stage biopharmaceutical company, has a lead program entering Phase 3 for hypertriglyceridemia. The company’s cardiovascular programs take advantage of the staff’s expertise in the field of lipid science and the acknowledged therapeutic benefits of essential fatty acids in cardiovascular disease. In addition to Amarin’s lead program, their pipeline includes programs in myasthenia gravis, Huntington’s disease, Parkinson’s disease and epilepsy. For further information, visit the Company's web site at www.amarincorp.com.

MondayNov 03, 2008 4:11 am

Midnight Oil Exploration Ltd. (TSX: MOX CN)

Midnight Oil Exploration Ltd. (TSX: MOX CN), a top quality junior exploration and production company, focuses on selected multi-zone, high-potential areas of the Western Canadian Sedimentary Basin. The company has a high-end technical team with experience, expertise, and innovative business execution skills that provide a competitive edge. Midnight's investment strategy is driven by a risk-balanced portfolio of high-potential exploration and development prospects and strategic acquisitions. For further information, visit the Company's web site at www.midnightoil.ca.

MondayNov 03, 2008 4:10 am

MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK)

MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK), a pharmaceutical company, is focused on developing and commercializing anti-infective drug products that address unmet medical needs in anti-infective therapy. The company’s aim is to develop a portfolio of drugs based on their biological finding that bacteria are killed more efficiently and effectively when exposed to antibiotics in front-loaded, sequential bursts, or pulses, than those exposed to standard antibiotic treatment regimens. For further information, visit the Company's web site at www.middlebrookpharma.com.

MondayNov 03, 2008 4:09 am

Metabasis Therapeutics, Inc. (NASDAQ: MBRX)

Metabasis Therapeutics, Inc. (NASDAQ: MBRX), a biopharmaceutical company, focuses their efforts on discovering, developing and commercializing innovative drugs by applying its scientific expertise, proprietary technologies and unique capabilities for targeting the liver and liver pathways. The company has established advanced research programs and a broad pipeline of product candidates, all of which were developed through the leveraging of their proprietary technologies. For further information, visit the Company's web site at www.mbasis.com.

MondayNov 03, 2008 4:09 am

Memory Pharmaceuticals Corp. (NASDAQ: MEMY)

Memory Pharmaceuticals Corp. (NASDAQ: MEMY) is a biopharmaceutical company focused on developing novel drugs designed to treat debilitating central nervous system (CNS) disorders, many of which significantly impair memory and other cognitive function. The company utilizes their staff’s expertise of the neuronal pathways involved in memory formation and cognition to identify highly relevant targets. By using in-house expertise in drug discovery and development, Memory Pharmaceuticals has generated a diverse pipeline of promising drug development programs. For further information, visit the Company's web site at www.memorypharma.com.

MondayNov 03, 2008 4:08 am

MediciNova, Inc. (NASDAQ: MNOV)

MediciNova, Inc. (NASDAQ: MNOV), a biopharmaceutical company, is dedicated to acquiring and developing innovative, small-molecule therapeutics designed to treat diseases with medical needs that are currently unmet. By strategically forming alliances with other pharmaceutical companies, the company holds rights to a diversified portfolio of clinical and preclinical product candidates. MediciNova believes each of these candidates has a well-characterized and unique therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. For further information, visit the Company's web site at www.medicinova.com.

Site Search

Company Search

Misonix, Inc. (NASDAQ: MSON)

American Lorain Corporation (OTC BB: ALRC)

MiMedx Group, Inc. (OTC BB: MDXG)

Millennium India Acquisition Company, Inc. (NASDAQ: SMCG)

Amarin Corporation plc (NASDAQ: AMRN)

Midnight Oil Exploration Ltd. (TSX: MOX CN)

MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK)

Metabasis Therapeutics, Inc. (NASDAQ: MBRX)

Memory Pharmaceuticals Corp. (NASDAQ: MEMY)

MediciNova, Inc. (NASDAQ: MNOV)

Market Basics

Newsletter Publishers

Public Companies